Gene · 6103
Papers1,847
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,847
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical Spectrum and Molecular Characteristics of Inherited Ocular Diseases in a Cohort of Pediatric Patients With Infantile Nystagmus Syndrome. | Invest Ophthalmol Vis Sci | 2025 | 40232708 | PubTator, text mining | PubMed |
| lncRNA PAN3-AS1 Modulates Cilium Assemble Signaling Pathway Through Regulation of RPGR as a Potential MS Diagnostic Biomarker: Integrated Systems Biology Investigation. | J Mol Neurosci | 2025 | 40227518 | PubTator, text mining | PubMed |
| A previously unreported RPGR gene variant in a female patient with X-linked retinitis pigmentosa. | Digit J Ophthalmol | 2025 | 40206241 | PubTator, text mining | PubMed |
| Whole-exome sequencing screening for candidate genes and potential pathogenic variants associated with early-onset high myopia in 47 Chinese families. | Sci Rep | 2025 | 40175531 | PubTator, text mining | PubMed |
| Identification of IDH3G, encoding the gamma subunit of mitochondrial isocitrate dehydrogenase, as a novel candidate gene for X-linked retinitis pigmentosa. | Genet Med | 2025 | 40119724 | PubTator, text mining | PubMed |
| Phenotypic characterization of a female patient with retinitis pigmentosa caused by a homozygous X-linked RPGR ORF15 mutation. | Am J Ophthalmol Case Rep | 2025 | 40104205 | PubTator, text mining | PubMed |
| 7 Tesla MRI Reveals Brain Structural Abnormalities and Neural Plasticity in RPGR-Related Retinitis Pigmentosa. | J Clin Med | 2025 | 40095571 | PubTator, text mining | PubMed |
| Retinitis Pigmentosa GTPase Regulator-Associated X-Linked Retinitis Pigmentosa: Molecular Genetics and Clinical Characteristics. | Am J Ophthalmol | 2025 | 40057012 | PubTator, text mining | PubMed |
| Retinal Disease Variability in Female Carriers of RPGR Variants Associated with Retinitis Pigmentosa: Clinical and Genetic Parameters. | Genes (Basel) | 2025 | 40004550 | PubTator, text mining | PubMed |
| Unveiling the Genetic and Phenotypic Landscape of a Chinese Cohort With Retinitis Pigmentosa. | Mol Genet Genomic Med | 2025 | 39988772 | PubTator, text mining | PubMed |
| Reproductive counseling and decision making in females affected by X-linked inherited retinal disease: perspectives from carriers. | Ophthalmic Genet | 2025 | 39950494 | PubTator, text mining | PubMed |
| Pre-Clinical and Clinical Advances in Gene Therapy of X-Linked Retinitis Pigmentosa: Hope on the Horizon. | J Clin Med | 2025 | 39941570 | PubTator, text mining | PubMed |
| Characterizing the Genetic Basis for Inherited Retinal Disease: Lessons Learned From the Foundation Fighting Blindness Clinical Consortium's Gene Poll. | Invest Ophthalmol Vis Sci | 2025 | 39908130 | PubTator, text mining | PubMed |
| Quantification of Fundus Autofluorescence Features in a Molecularly Characterized Cohort of >3500 Patients with Inherited Retinal Disease from the United Kingdom. | Ophthalmol Sci | 2025 | 39896422 | PubTator, text mining | PubMed |
| The Role of Geometry on the Ease of Solidification Inside and Out of Cylindrical Nanopores. | Langmuir | 2025 | 39718344 | PubTator, text mining | PubMed |
| Subretinal Gene Therapy Drug AGTC-501 for XLRP Phase 1/2 Multicenter Study (HORIZON): 24-Month Safety and Efficacy Results. | Am J Ophthalmol | 2025 | 39643074 | PubTator, text mining | PubMed |
| Refractive Error in Inherited Retinal Disease. | Am J Ophthalmol | 2025 | 39303928 | PubTator, text mining | PubMed |
| Validation of Nanopore long-read sequencing to resolve RPGR ORF15 genotypes in individuals with X-linked retinitis pigmentosa. | Eur J Hum Genet | 2025 | 38969740 | PubTator, text mining | PubMed |
| An investigation of a hemophilia A female with heterozygous intron 22 inversion and skewed X chromosome inactivation. | Front Genet | 2024 | 39834547 | PubTator, text mining | PubMed |
| Long-Term Visual Field Progression in X-Linked Retinitis Pigmentosa Patients. | Diagnostics (Basel) | 2024 | 39767158 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6103/papers?page=5